Clinical trial
An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV
NCT01684111 is registered in ClinicalTrials.gov with Aktion Bronchialkarzinom e.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV
- Lead sponsor
- Aktion Bronchialkarzinom e.V.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- Not reported
- Enrollment
- 7 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.